ÂÜÀòÂÒÂ×

Olivier Laurent is an accomplished biotechnology executive with extensive experience leading research and development efforts. Currently serving as Chief Scientific Officer at Mirador Therapeutics, Olivier has held significant leadership positions such as Chief Scientific Officer and Head of R&D at Prometheus Biosciences, where innovative approaches to treating immune-mediated diseases were developed. Previous roles include Chief Scientific Officer at Dauntless Pharmaceuticals and Intrepida Bio, along with critical positions at Pfizer, where Olivier oversaw protein science and therapeutic peptide strategies. Olivier's academic foundation includes a Ph.D. in Cell Biology from Université Joseph Fourier and a Master's in Molecular and Cellular Biology from École normale supérieure de Lyon.